Exchange: NASDAQ·Updated 10:37 AM EDT
CLSD logo

CLSD Clearside Biomedical Inc

$0.249
$0.0013
(0.52%)
Today
Reported EarningsAug 18
Mkt Cap$1.3M
Vol3.00

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases. Its pipeline includes CLS-AX, an Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
39

Bearish Sentiment

How do you feel about CLSD?

fistedhole
$CLSD this was one of the first stocks I really invested in. Never really made money. Then called it quits when Covid tanked it. Sad to see where it ended up. Forget was there main thing was? Super cordia micro injections or something. Used to even listen to the calls. Good times being 19 and learning about the market from this one
SQUEAKSBANDIT
$CLSD did the new shares start trading anywhere? has anyone gotten any consideration yet

Advertisement|Remove ads.